Analysts Think CLNN Stock Has 127% Potential Upside
Автор: Penny Stocks - NAK stock, TXMD stock, ATOS stock
Загружено: 2021-05-04
Просмотров: 430
Описание:
Analysts Think CLNN Stock Has 127% Potential Upside #shorts
Analysts Think this Stock Has 127% Potential Upside.
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. Today Analyst firm Cantor Fitzgerald, initiated coverage on Clene, giving an Overweight rating on the company. The firm also set a $22 price target on the stock suggesting a potential upside of 127% compared to its current price.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: